January is Cervical Cancer Awareness Month, and research shows that late-stage cervical cancer appears to be on the rise. Doctor Robert Debernardo with Cleveland Clinic said that could be due in part ...

Advanced cervical cancer remains a formidable clinical challenge, particularly in patients with locally advanced or recurrent disease. Over recent years, therapeutic strategies have evolved from ...

Share on Pinterest Results from a phase 3 clinical trial show promise for a new standard of care for treating people with advanced cervical cancer. AzmanL/Getty Images A phase 3 clinical trial ...

Most gynecologic oncologists and radiation oncologists would consider prescribing hormone therapy for patients with cervical ...

Study on the efficacy and toxicity of pamiparib combined with tamoxifen in the treatment of patients with epithelial ovarian cancer with biochemical recurrence during first-line PARPi maintenance ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. It’s easy to think cervical cancer could be 100 ...

The Food and Drug Administration (FDA) has recently approved Keytruda (pembrolizumab) plus chemoradiotherapy for the treatment of patients with stages 3 to 4A cervical cancer. The recent approvalof ...

New results from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study showed that a combination of pembrolizumab and concurrent chemoradiotherapy (CCRT) continues to ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from the final analysis of the phase 3 A18 ...

STA. BARBARA, Pangasinan (PIA) — As the Philippines marks Cervical Cancer Consciousness Month, the Region 1 Medical Center ...